Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Health
Results: 7717-7728 of 8081
Daewoong Pharmaceutical to Participates in CPHI Worldwide 2023, Showcasing Own Novel Drug in the Global Market
Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study
ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
Alkermes to Report Third Quarter Financial Results on October 25, 2023
Inside information: Bioretec estimates that the approval of the European market authorization for the biodegradable RemeOs™ trauma screw will move to the first quarter of 2024
TaCa Healthcare is Revolutionizing the Healthcare Industry by Making Elective Secondary Care Surgeries More Affordable and Accessible.
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study
Seegene Reinforces Commitment to Strong ESG Management with 100% Recyclable, Styrofoam-Free Shipping Boxes
Tiziana Life Sciences Announces Allowance By FDA For At-Home Dosing Of Intranasal Foralumab For Multiple Sclerosis Treatment
World Menopause Day: International SOS Encourages Organisations to Provide Workplace Support and Raise Awareness on Menopause
Prev
Page
1
2
…
643
644
645
…
673
674
Next
Page
